|
First-Line Lorlatinib Versus Crizotinib in ALK-Positive NSCLC: Japanese Subgroup Analysis of CROWN |
|
|
|
Titel: |
First-Line Lorlatinib Versus Crizotinib in ALK-Positive NSCLC: Japanese Subgroup Analysis of CROWN |
Auteur: |
Hayashi, Hidetoshi Teraoka, Shunsuke Goto, Yasushi Kumagai, Toru Nishio, Makoto Sugawara, Shunichi Oizumi, Satoshi Matsumura, Masakazu Okura, Masayuki Peltz, Gerson Kato, Terufumi |
Verschenen in: |
JTO clinical and research reports |
Paginering: |
Jaargang 4 () nr. 4 pagina's p. |
Jaar: |
2023 |
Inhoud: |
|
Uitgever: |
The Authors |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|